secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2025-12-22T23:59:59+00:00
Accession:  0001104659-25-123500
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransCode Therapeutics appoints Jack Stover to Board of Directors
-----------------------------------------------------------------

- Jack Stover appointed to Board effective Dec 19, 2025; joins Audit and Nominating Committees.
- Dr. Magda Marquet resigns from Audit Committee following Stover's appointment.
- Stover brings over 30 years life sciences leadership; currently Chairman of Traws Pharma (TRAW).
- Previously CEO of Antares Pharma (ANTR), led sale to Halozyme for over $900 million.
- Stover is designated as independent director and financial expert.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925123500/0001104659-25-123500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925123500/tm2534017d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-123500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer